Info@ThinkPinkRocks.com

Celon, Lupin sign definitive agreement to develop generic version of Advair Diskus

Pharma Major Lupin Limited (Lupin) and Celon Pharma S.A. (Celon) announced today that they have entered into a definitive agreement under which the companies will jointly develop a fluticasone/salmeterol dry powder inhaler (DPI) product which is a generic version of GlaxoSmithKline’s Advair DiskusĀ®.

Visit site:
Celon, Lupin sign definitive agreement to develop generic version of Advair Diskus

Share

Leave a Reply

Solve : *
14 − 12 =